Imprimis Pharma (IMMY) Misses Q1 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Imprimis Pharma (IMMY) Misses Q1 EPS by 8c

Imprimis Pharmaceuticals Announces First Quarter 2015 Financial Results and Provides Business Update

May 13, 2015 4:05 PM EDT

SAN DIEGO, May 13, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced its financial results for the first quarter 2015 ended March 31, 2015.  Management will discuss the financial results and recent business developments on a conference call this afternoon.

Key First Quarter 2015 Accomplishments and Recent Developments

Revenue of approximately $1.6 million during the first quarter of 2015, compared to $2,000 during the first quarter of 2014; Adjusted EBITDA... More